Qin Miaomiao, Wang Danping, Fang Yijiao, Zheng Zhiying, Liu Xinyang, Wu Fan, Wang Liangliang, Li Xiao, Hui Bingqing, Ma Shijie, Tang Weiwei, Pan Xiongxiong
Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Front Oncol. 2021 Jun 21;11:647854. doi: 10.3389/fonc.2021.647854. eCollection 2021.
Immune cells infiltrating tumors are capable of significantly impacting carcinogenesis through cancer promotion and anticancer responses. There are many aspects of hepatocellular carcinoma (HCC) related T lymphocytes that are undergoing extensive studies, whereas the effect exerted by B lymphocytes remains a less researched area. In this study, the latest research on the effect of B lymphocytes as they infiltrate tumors in relation to HCC is presented. Their prognosis-related importance is analyzed, along with their function in the tumor microenvironment (TME), as well as the way that B cell biology can be employed to help create a B cell therapy strategy for HCC.
浸润肿瘤的免疫细胞能够通过促进癌症和抗癌反应对肿瘤发生产生重大影响。肝细胞癌(HCC)相关T淋巴细胞的许多方面正在进行广泛研究,而B淋巴细胞所发挥的作用仍是一个研究较少的领域。在本研究中,展示了关于B淋巴细胞浸润肿瘤与HCC相关效应的最新研究。分析了它们与预后相关的重要性、在肿瘤微环境(TME)中的功能,以及如何利用B细胞生物学来帮助制定HCC的B细胞治疗策略。